Brownstone » Jaridar Brownstone » idon » Kira don Sake Bitar Taro Na Labarai akan Alurar rigakafin Covid
Kira don Sake Bitar Taro Na Labarai akan Alurar rigakafin Covid

Kira don Sake Bitar Taro Na Labarai akan Alurar rigakafin Covid

SHARE | BUGA | EMAIL

A cikin shekarun da na yi aiki a matsayin editan aboki (don Jaridar Amurka ta Epidemiology), Na ga dukan bakan na "takwarorinsu reviews" - daga ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun mawallafa waɗanda a fili sun ba da gudummawar sa'o'i da yawa a cikin aikin don tsara sake dubawa wanda ke nuna rashin kulawa da rashin iyawa. Na karanta sake dubawa na abokantaka daga masu sha'awar marubuta da kuma sake dubawa na maƙiyansu. (Ba shi da wuya a gane ta hanyar sautin.) A cikin aikin kimiyya, har yanzu ’yan Adam suna nuna hali irin na mutane.

Al'amura sun yi muni yayin bala'in. Nazarin da ya yaba da allurar rigakafin Covid an tabbatar da su cikin sauri "an sake duba takwarorinsu," yayin da yake da mahimmanci, bitar takwarorinsu bayan bugawa ya kasance. hanawa. A sakamakon haka, yanzu muna da tarin tarihin da aka buga na kimiyya mara kyau. Ba za a iya share shi ba, amma lokaci ya yi da za a fara gyara rikodin.

Mujallolin likitanci ba dandamali bane. Na farko, babu wani sashe na yau da kullun don buɗe bitar takwarorinsu na labaran da aka buga tuntuni. Na biyu, masu gyara ba su da sha'awar fallasa labaran karya da aka buga a cikin mujallunsu. Na uku, da ƙididdigewa inji har yanzu a wurin. Ya zuwa yanzu, na iya karya shi kawai da zarar, kuma ba abu ne mai sauƙi ba.

Don haka, ta yaya za mu yi ƙoƙari mu gyara rikodin, kuma a ina?

Bari in ba da shawara ga takwarorina a fannin ilimin cututtuka, ilimin halittu, da kuma fannonin dabaru waɗanda suka kiyaye tunaninsu mai mahimmanci yayin bala'in. Zaɓi labarin ɗaya ko fiye game da rigakafin Covid kuma ƙaddamar da bitar takwarorin ku ga Jaridar Brownstone. Idan yana da ban sha'awa kuma an rubuta shi sosai, akwai damar da za a buga. Ina ba da shawarar zabar ceri: nemo waɗancan labaran da aka bita da su waɗanda suka fi fusata ku, ko dai saboda suna da tsarki. maganar banza ko kuma saboda madaidaicin bayanin ya kasance ban mamaki daban. Kuma idan kun buga gajerun suka akan Twitter (yanzu X) ko cikakken bita akan wasu dandamali, fadada, sake dubawa, kuma ƙaddamar da su zuwa Brownstone. Wataƙila za mu iya ƙirƙira ƙira a hankali na bita mai mahimmanci, maido da wasu dogara ga hanyar kimiyya da kimiyyar halittu.

Ga misali.

Bita da Sake-Bincike na Bincike a Ontario, Kanada

Aka buga a cikin British Medical Journal a watan Agusta 2021 takarda sun ba da rahoton tasirin rigakafin mRNA a farkon 2021, jim kaɗan bayan izininsu.

Wannan binciken ya kasance irin na nazarin alluran rigakafi daga wancan lokacin. An kiyasta tasiri a cikin yanayin "ainihin-duniya"; wato binciken lura a lokacin yakin neman zabe. Lokacin karatun (tsakiyar Disamba 2020 zuwa tsakiyar Afrilu 2021) ya haɗa da kololuwar ruwan sanyi na Covid a farkon Janairu. Za mu tattauna daga baya wani ƙaƙƙarfan son zuciya da ake kira rikicewa ta hanyar haɗarin kamuwa da cuta ta baya.

Zane-zane ya kasance bambance-bambancen nazarin nazarin shari'ar, ƙirar gwaji-mara kyau. Abubuwan da suka cancanta sun yi gwajin PCR saboda alamun Covid-kamar. Abubuwan da aka gwada tabbatacce; controls gwada korau. Kamar yadda aka saba, an ƙididdige ƙididdige ƙididdiga, kuma an ƙididdige tasiri a matsayin 1 ban da madaidaicin rabo (an bayyana a cikin kashi). Girman samfurin ya kasance babba: lokuta 53,270 da sarrafawa 270,763.

Source: wani ɓangare na adadi 1 a cikin labarin

Marubutan sun ba da rahoton sakamako masu zuwa masu zuwa ( rubutun nawa):

"An lura da tasirin maganin alurar riga kafi akan kamuwa da cutar ≥14 kwanaki bayan kashi ɗaya shine 60% (95% tazarar amincewa 57% zuwa 64%), yana ƙaruwa daga 48% (41% zuwa 54%) a 14-20 kwanaki bayan kashi ɗaya zuwa 71% (63% zuwa 78%) a cikin kwanaki 35-41. An lura da tasirin rigakafin ≥7 kwanaki bayan allurai biyu shine 91% (89% zuwa 93%)."

Kamar kusan kowane nazarin tasiri, marubutan sun watsar da abubuwan da suka faru na farko. Kamar yadda bayani ya gabata wasu wurare, wannan aikin yana gabatar da son zuciya da ake kira lokacin mutuwa, ko nuna son zuciya ta taga. Ba wai kawai yana ɓoye yuwuwar illolin cutarwa da wuri ba, amma har ma yana haifar da ƙima na inganci. RFK, Jr. ya yi ishara da wannan son zuciya ta hanyoyin da ba na fasaha ba (duba shirin bidiyo).

The daidai hanya mai sauki ne. Ya kamata mu kiyasta tasiri daga gudanar da kashi na farko zuwa lokaci na gaba (gina rigakafi). Tebur na da ke ƙasa yana nuna bayanan binciken da sakamakon sabon bincike. Kowane jere yana nuna ƙididdige tasiri zuwa ranar da aka nuna.

Tasiri ya kasance mara kyau a ƙarshen makonni biyu na farko bayan kashi na farko kuma ya kai kusan 30% kafin kashi na biyu, ba 70%. Ya kai kusan kashi 50% ta lokacin cikakken rigakafi, ba 90%. Kodayake ƙididdiga na ba a daidaita su ba, eTable 2 (karin kayan) yana nuna cewa da ƙyar daidaitawa ya canza kiyasin marubuta.

Sakamakona har yanzu yana nuna son kai, duk da haka, ta abin da na kira a baya "mai ruɗar haɗarin kamuwa da cuta."

Hoton da ke ƙasa an ɗauke shi daga gidan yanar gizon Kiwon Lafiyar Jama'a Ontario. Layin baƙar fata yana nuna matsakaicin mirginawar kwanaki 7 na sabbin lokuta. Na kara jajayen layukan da ke nuna lokacin nazarin, an kasu kashi biyu. Na kuma kara kiyasin adadin mutanen da aka yi wa allurar a kowane tazara.

Tazara ta farko, wacce ta ƙunshi kololuwar ruwan sanyi, lokaci ne na jinkirin farkon yaƙin neman zaɓe. A wancan lokacin, an karkatar da rabon matsayin rigakafin zuwa ga rashin rigakafin, wanda ke nufin cewa. Matsayin rashin rigakafin ya faru ya zo daidai da babban yuwuwar kamuwa da cutar. Sabanin haka, yawan kamuwa da cuta a bayan fage ya yi ƙasa a yawancin lokaci na biyu, lokacin da mutane miliyan da yawa suka karɓi kashi na farko. A tsakiyar watan Maris ne adadin sabbin shari'o'in ya ketare layin da aka dage. A taƙaice, haɗin gwiwar da ke tsakanin allurar rigakafi da kamuwa da cuta ya ruɗe sosai saboda yanayin lokaci a cikin haɗarin kamuwa da cuta. Ko da allurar placebo da ta bayyana tasiri.

Ba zan iya cire son zuciya ba, kuma yana da ƙarfi. Tasirin gaskiya, idan akwai, ya fi ƙanƙanta fiye da ƙididdiga na ƙididdigewa bayan kawar da son zuciya mara mutuwa. Ko yana da kashi 10% ta makonni shida ko 20% babu bambanci. Wannan ba maganin rigakafi ba ne.

Mawallafa sun yi amfani da wani rukunin shari'ar: asibiti ko mutuwa. Wannan bayanan yana ƙarƙashin ba kawai ga son rai na baya ba amma har ma da lafiyayyen rigakafin son zuciya. Ba zan iya ba da gyara ba, duk da haka. Yawancin bayanai na lokuta an kashe su saboda ƙananan lambobi, kuma ƙungiyar kulawa ba ta da kyau. Sun yi amfani da "rukunin sarrafawa iri ɗaya kamar na binciken sakamako na farko na farko (watau mutanen da ke da alamun da suka gwada rashin lafiyar SARS-CoV-2)." Wannan cin zarafi ne na ainihin ƙa'idar ƙirar gwaji-mara kyau. Ya kamata a kwantar da abubuwan sarrafawa a asibiti ko kuma mutanen da suka mutu waɗanda suka gwada rashin lafiya.

Jumlar da ke gaba tana nuna rashin fahimtar tsarin koma baya da suka dace. Sun rubuta, "Mun yi amfani da nau'ikan koma bayan dabaru masu yawa don ƙididdige ƙimar rashin daidaituwa, kwatanta rashin daidaiton alurar riga kafi ( rubutuna na) tsakanin gwaji masu inganci da gwajin sarrafawa mara kyau (tare da mutanen da ba a yi musu alluran rigakafi azaman rukunin tunani)." Matsakaicin abin dogara shine matsayi na sarrafa shari'a (ƙididdigar log na kasancewa harka a fasaha, ana kwatanta rashin daidaiton kasancewa harka (da kasancewa mai sarrafawa), ba rashin daidaituwar alurar riga kafi ba.

Abin mamaki, da aka buga Karin kayan Har yanzu yana ɗauke da taken "SIRRIN - BA DON RABAWA, 5 Aug 2021." A cikin zamanin Covid ne kawai za ku iya samun irin wannan ɓacin rai. A nan mun lura da nuna son kai (rashin kulawa) yadda ake amfani da takarda da ke ba da labari.

Zan kawo karshen bita na da batun da na fi so: sakamakon banza.

Hoton da ke ƙasa yana nuna ƙididdiga na tasiri, kamar yadda marubuta suka ƙididdige su. Kibiya tana nuna sakamakon da ba shi da ma'ana. Ba ma tsammanin wani ƙarin fa'ida na kashi na biyu a cikin kwanaki 6 na allurar, duk da haka tasirin ya karu, kusan kaiwa ga kimantawa na tazara na gaba (kwanaki 7+). Idan kiyasin na kwanaki 0-6 yana nuna son kai a fili, me yasa za mu amince da na gaba?

Source: Hoto na 2 a cikin labarin

Epilogue

Kamar yadda na rubuta a farkon, ya kamata mu yi ƙoƙari mu gyara tarihin tarihi. Hanya ce mai nisa a gaba, amma kamar yadda karin magana ke cewa, “Tafi na mil dubu yana farawa da taki ɗaya.” Ina jan hankalin kwararrun masana hanyoyin da suka saba wargaza karatu mara kyau da sukar hanyoyin girgiza. Yawancinsu sun yi shiru a duk lokacin bala'in, mai yiwuwa suna tsoron sakamakon kalubalantar labarin "aminci da inganci".

Bari mu fara karanta sake dubawa marasa tsoro na binciken da suka ba da rahoton ingantaccen tasirin rigakafin Covid, wanda ya tabbatar da cewa karya ne. Babu ƙarancin matsaloli don ganowa, haskakawa, da gyara, idan zai yiwu, tare da ainihin bayanai ko kwaikwaiyo:

Idan ba mu yi wannan aikin ba, za mu ci gaba da karatu ƙarya, ƙididdiga na tushen tasiri na ceton rayuka. Ya kusa? 2.5 miliyan, kamar yadda wasu suka yi iƙirari, ko wanda ba a iya ganowa a cikin kididdigar mace-mace, ko mai yiwuwa game da sifili? Kuma ko za mu taba samun wasu amsoshi daga wurin dacewa gwaji?

An sake buga shi daga Medium


Shiga cikin tattaunawar:


An buga ƙarƙashin a Commonirƙirar Commonabi'a Mai Creativeayatarwa 4.0 Licenseasashen Duniya
Don sake bugawa, da fatan za a saita hanyar haɗin yanar gizo zuwa asali Cibiyar Brownstone Labari da Marubuci.

Mawallafi

  • Eyal Shahar

    Dokta Eyal Shahar farfesa ne a fannin kiwon lafiyar jama'a a fannin cututtukan cututtuka da kididdiga. Binciken nasa yana mayar da hankali ne akan ilimin cututtuka da kuma hanyoyin. A cikin 'yan shekarun nan, Dr. Shahar ya ba da gudummawa sosai ga hanyoyin bincike, musamman a fannin zane-zane da kuma son zuciya.

    Duba dukkan posts

Gudummawa A Yau

Tallafin kuɗin ku na Cibiyar Brownstone yana zuwa don tallafawa marubuta, lauyoyi, masana kimiyya, masana tattalin arziki, da sauran mutane masu jaruntaka waɗanda aka tsarkake su da sana'a da gudun hijira a lokacin tashin hankalin zamaninmu. Kuna iya taimakawa wajen fitar da gaskiya ta hanyar aikin da suke gudana.

Yi rajista don Jaridar Brownstone Journal Newsletter

Shiga Jama'ar Brownstone
Samu Jaridar Mu KYAUTA